DeepTech & Hardware
Support for companies involved in advanced technology and hardware innovation, including robotics and semiconductors.
200 Investors with DeepTech & Hardware industry focus

Bessemer Venture Partners is a leading venture capital firm that partners with entrepreneurs from their early days through every stage of growth. With a history rooted in the Carnegie Steel empire, Bessemer has a long tradition of investing in transformative companies across various industries. The firm is committed to supporting entrepreneurs with capital, strategic guidance, and a robust network to build enduring companies.

Established in 1996, VantagePoint Capital Partners is a global venture investor with a focus on energy innovation and efficiency. With over $4 billion under management, the firm supports companies from start-up to scale-up, providing not only capital but also strategic resources, partnership alliances, and ongoing support. Headquartered in Silicon Valley, VantagePoint has offices in Beijing and strategic partners worldwide, emphasizing its commitment to energy innovation and efficiency.

Pittsburgh Life Sciences Greenhouse (PLSG) is a leading life sciences investment firm in Western Pennsylvania, dedicated to fostering innovation and commercialization in the life sciences sector. PLSG supports entrepreneurs and emerging companies by providing funding, strategic guidance, and access to resources, with a focus on improving healthcare outcomes and driving economic growth in the region. The firm is deeply connected to the growing impact of data analytics in healthcare and is committed to supporting underserved groups through initiatives like the 'Under 40, Underserved Advisory Board'.

Serra Ventures, LLC is a venture capital firm that focuses on catalyzing innovation by funding early-stage tech startups across the United States. With a strong presence in Champaign, Chicago, San Diego, and Park City, Serra Ventures has funded over 100 early-stage tech startups, emphasizing its commitment to fostering growth and innovation in the tech industry.

SV Health Investors is a leading venture capital firm focused on investing in innovative healthcare companies. With a mission to transform healthcare one investment at a time, SV Health Investors supports diverse entrepreneurs in creating breakthrough companies and treatments. The firm has a strong track record of investing in companies that improve healthcare through innovative care delivery models, next-generation digital health technologies, and groundbreaking medical products. SV Health Investors is committed to diversity and believes that it strongly contributes to success.

3E Bioventures Capital is a venture capital firm focused on life sciences, investing in global health innovators. The firm targets Biotech, including new drugs, modalities, and drug discovery platforms, as well as TechBio, which merges biology and technology to disrupt traditional paradigms. 3E Bioventures follows a science-driven, entrepreneur-friendly investment approach, collaborating with companies and research institutions to develop solutions for unmet medical needs. The firm's philosophy is encapsulated in its name, 3E: Expertise, Efficiency, Execution.

Flare Capital Partners is a leading venture capital firm dedicated to transforming the healthcare industry by investing in innovative healthcare technology companies. The firm partners with exceptional founders to address significant market opportunities, aiming to improve healthcare outcomes and reduce costs. With a deep understanding of the healthcare market, Flare Capital leverages its extensive industry connections and expertise to support the growth and success of its portfolio companies.
KKR is a leading global investment firm founded in 1976, known for its pioneering role in the private equity industry. The firm is committed to delivering strong returns and shared success to its clients and the world at large. KKR invests across various asset classes, including private equity, infrastructure, real estate, and credit, with a focus on fortifying companies and communities. The firm emphasizes a culture of shared ownership and long-term value creation, aligning its interests with those of its investors and portfolio companies.

IU Ventures is a 501(c)(3) affiliate of Indiana University focused on advancing high potential new venture opportunities. It supports IU students, faculty, staff, and alumni in creating and growing startups that generate significant social and economic impact for Indiana University, the state of Indiana, and the world. The organization manages several investment programs, including the IU Philanthropic Venture Fund, IU Angel Network, and IU Founders & Funders Network, to foster a pervasive entrepreneurial culture and contribute to economic development.

Warburg Pincus LLC is a pioneer in global growth investing, operating as a private partnership since 1966. The firm focuses on helping investors and management teams achieve enduring success across market cycles. With over $86 billion in assets under management and more than 230 companies in its active portfolio, Warburg Pincus is diversified across stages, sectors, and geographies. The firm has invested in over 1,000 companies globally across private equity, real estate, and capital solutions strategies.

Research Corporation Technologies (RCT) is a technology investment and management company based in Tucson, Arizona. Founded in 1987, RCT provides early-stage funding and development for promising biomedical companies and technologies, focusing on innovations originating from universities and research institutions worldwide. With assets exceeding $500 million, RCT advances technology development through venture investments, partnerships, and special licensing programs, supporting the commercialization of academic innovations.

Future Planet Capital is an impact-led venture capital firm based in the UK with a global reach. The firm focuses on investing in high-growth companies that address global challenges profitably, aligning with the UN Sustainable Development Goals. With over $400 million in assets under management and a portfolio of 140 companies, Future Planet Capital leverages its connections with top universities and research ecosystems to back innovative solutions in climate change, education, health, security, and sustainable growth.

Glynn Capital is a private and public technology investment firm focused on long-term investments in technology growth companies. The firm aims to partner with exceptional teams leveraging disruptive technologies to address markets ripe for change. Glynn Capital invests in both private early-growth stage companies and public durable growth companies, seeking to add value through experience and networks.

Mitsui & Co. Global Investment, Inc. is a venture capital firm with over 20 years of experience, focusing on guiding entrepreneurs onto the global stage. The firm goes beyond financial support, offering strategic guidance and leveraging its vast network to facilitate key partnerships. With a commitment to improving human welfare, Mitsui partners with exceptional teams to reinvent industries worldwide.

Triangle Angel Partners (TAP) is an angel fund based in the Research Triangle Park area of North Carolina. Formed in 2011, TAP aims to leverage the expertise and capital of its members to support local entrepreneurs in high-tech start-ups. TAP provides not only financial investment but also mentoring, counseling, and access to a vast network of potential investors, customers, and strategic partners. The firm has launched two funds, TAP I and TAP II, with a focus on investing in companies within a half-day's drive of Research Triangle Park.
NSG Ventures is a global biotech venture capital firm managed by founders and scientists. The firm is dedicated to investing in innovative solutions to tackle humanity's greatest challenges, particularly diseases. NSG Ventures partners with exceptional teams to push scientific boundaries and achieve medical breakthroughs.

Theradaptive
Theradaptive’s RESTORE Trial Initiation for OsteoAdapt™ DE
Theradaptive launches RESTORE Phase I/II trial of OsteoAdapt™ DE for faster, precision bone healing in craniofacial injuries. MTEC-funded study targets improved recovery for military and civilian patients.
Altec
Autonomous Rehabilitation Device for Improved Recovery in Warfighters
The OSCIR platform—developed by Altec Inc in collaboration with the Naval Health Research Center—is bringing clinical-grade, real-time movement analysis to the front lines. Funded under MTEC-22-02-MPAI
Medical Technology Enterprise Consortium (MTEC)
The Power of IP: Why It Matters to MTEC and Our Mission
MTEC President highlights intellectual property as essential to protecting innovation, attracting investment, and enabling collaboration. A new partnership with Patenter.io supports members in managing and commercializing IP.
George Mason University
SMART-US Wearable Ultrasound + AI Device for Muscle Force Prediction
AI-powered ultrasound in a wearable—SMART-US delivers lab-grade muscle-force insights anywhere.